Ausgabe 3/2012
Inhalt (20 Artikel)
ASH 2011: “Real generosity toward the future lies in giving all to the present”
Michael Steurer
ASH 2011—Hodgkin’s disease and the high grade lymphomas
Wolfgang Willenbacher, Ella Willenbacher
Treating T-cell lymphoma: is there a light at the end of the tunnel?
Georg Hopfinger, Olaf Merkel, Thomas Melchardt, Richard Greil
Advanced neuroimaging techniques for diagnosis and treatment evaluation in neuro-oncology
Bernhard Schuknecht, Krisztina Baráth, Silvia Hofer
Drug therapy for recurrent, progressive, atypical, and malignant meningiomas
Christine Marosi
Current treatment of low grade gliomas
Martin J. van den Bent, Tom J. Snijders, Jacoline E. C. Bromberg
Update on molecular and genetic alterations in adult medulloblastoma
Marcel Kool, Andrey Korshunov, Stefan M. Pfister
The End-of-Life in patients with glioma and their families
Christine Marosi, Birgit Flechl, Stefan Oberndorfer
New drugs for head and neck cancer
József Dudás, Heinz Zwierzina, Georg Mathias Sprinzl
Sorafenib in thyroid cancer—a retrospective case series
Gabriele Gamerith, Andreas Pircher, Arno Amann, Katharina Cima, Klaus Gasser, Markus Lenzhofer, Peter Lind, Evelyne Bareck, Ewald Wöll, Wolfgang Hilbe